We understand why some people at the grassroots level of psychedelics may dislike the recent attention from capital markets.

“Money can contaminate motives” as @tferriss has said.

This is absolutely true in any industry, and psychedelic medicine is not immune from bad actors.

However - Even though many psychedelic practices and traditions have been happening for thousands of years, it is obvious that bringing these treatments mainstream to our healthcare system will require vast resources. Studies, regulation, consistency, safety, proper training, etc

We exist to help investors undertand more about this once-in-a-lifetime opportunity to revolutionize mental health and wellness.

It is our belief that attracting resources to the study and implementation of Psychedelics will do far more good than harm.

It is extremely rare for there to be such overlap between the interests of Venture Investors (ROI) and the general population (desire for health, wellness).

We will be doing our part to bring awareness and capital to the space, and we hope you all will too.

/end